This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
jarmoluk / Pixabay

This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?

According to a story from Forbes, a new drug developed by the company Regeneron has the potential to make a real difference for people with the homozygous form of familial…

Continue Reading This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
geralt / Pixabay

When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer

According to a story from FHM Pakistan, a recent study revealed the familial hypercholesterolemia patients are at a greater risk of stroke, heart attack, and other cardiovascular problems when they…

Continue Reading When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
katicaj / Pixabay

Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation

According to a story from bloomberg.com, the drug development company Arrowhead Pharmaceuticals, Inc. recently announced that its experimental product candidate AR0-ANG3 has earned Orphan Drug designation from the US Food…

Continue Reading Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
sabinurce / Pixabay

Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from brightsurf.com, familial hypercholesterolemia, a genetic condition that causes elevated levels of LDL cholesterol to appear at a young age, often goes undiagnosed. In fact, some…

Continue Reading Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from Healio, a recent study suggests that the addition of four more genes to the conventional genetic test used to diagnosed familial hypercholesterolemia could allow more…

Continue Reading Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

  Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…

Continue Reading Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference

New Research to be Presented In just a few days the American College of Cardiology will host their 68th Annual Scientific Session (ACC.19). It will be held in New Orleans,…

Continue Reading Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference
Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases
stevepb / Pixabay

Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases

According to a story from Pharmaphorum, there are a number of new treatments that have been introduced or have seen major strides in development over the last year. More patient…

Continue Reading Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases
New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program
QuinceMedia / Pixabay

New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

The Patient Advocate Foundation has recently begun to expand the reach of its popular Co-Pay Relief program. The Co-Pay Relief program is designed to provide financial assistance to qualifying patients.…

Continue Reading New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia

According to a story from the FH Foundation, the non-profit organization has released a vital consensus statement regarding the diagnosis of familial hypercholesterolemia, which is the most prevalent genetic cause…

Continue Reading New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia
New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
source: pixabay.com

New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia

According to a story from Cardiovascular Business, The FH Foundation, which is a frontrunning patient advocacy and research organization for familial hypercholesterolemia, recently announced that it has begun enrollment for…

Continue Reading New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need
source: pixabay.com

A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need

An article from SRN News is reporting that a lot of people with familial hypercholesterolemia are going through life without getting the treatments that could help them, such as statins.…

Continue Reading A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need
These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable
source: pixabay.com

These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable

According to a story from PR Newswire, the pharmaceutical companies Sanofi and and Regeneron Pharmaceuticals are implementing a plan to make Praluent injections more accessible and affordable for patients with…

Continue Reading These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable